pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
KRAS G12C · news · pharmadog
← back to KRAS G12C
News · KRAS G12C
6
stories
Sep 3, 26
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
biospace
Aug 26, 26
Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma race
fiercebiotech
Aug 25, 26
After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platform
fiercebiotech
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 study
endpoints
May 6, 26
Dr Pant on the Mechanism of Action of Daraxonrasib in PDAC
onclive
